Following the launch of QUVIVIQ™ (daridorexant) CIV on May 2, Idorsia Pharmaceuticals, U.S. Inc. announced that the first wave of patients has been prescribed the product through a pharmacy services provider. The pharmacy services provider is working with insurance companies to verify coverage, optimize benefits, explore patient assistance programs, and fulfill valid prescriptions – with the goal of ensuring maximum patient access and lowest out-of-pocket costs. Eligible patients may pay as low as $0 for the first 30-day prescription of QUVIVIQ and as low as $25 for each subsequent 30-day refill, complete with home delivery.
QUVIVIQ was approved by the Food and Drug Administration in early January for adults who have trouble falling or staying asleep (insomnia). The product was first commercially available on May 2, through the pharmacy services provider, and all retail pharmacies will be able to order product through their wholesalers starting on May 16.
“We are extremely excited that the first patients in the U.S. have been prescribed QUVIVIQ,” said Patricia Torr, President and General Manager of Idorsia U.S. “After the first week of product availability through our pharmacy services provider partnership, engagement with health care providers and patient adoption trends are very positive and encouraging.”
Insomnia is the most common sleep disorder, affecting more than 25 million adults in the U.S.1 Sleep is underrecognized as the third pillar of health, next to diet and exercise, particularly regarding the significant direct consequences it has on our daily lives. The effects of sleep, particularly lack of quality sleep, are felt by people during the day; it impairs health and daily life – from a weakened immune system to challenges with memory and attention.2,3
QUVIVIQ 25mg and 50mg is FDA approved and available for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. QUVIVIQ is recommended once per night, taken orally within 30 minutes before going to bed, with at least seven hours remaining prior to planned awakening.4
Adults struggling with sleep should speak with their doctor to see if QUVIVIQ is the right treatment option for them. For more information, see the Full Prescribing Information (PI and Medication Guide).